期刊文献+

MK-801诱导精神分裂症小鼠的c-Fos及NADPH氧化酶通路机制研究 被引量:3

Involvement of c-Fos and NADPH Oxidase Pathway in the Pathogenesis of Schizophrenia in Mice Induced by MK-801
原文传递
导出
摘要 目的:探讨MK-801诱导的精神分裂症小鼠的相关机制,为相关精神分裂症的临床研究和治疗提供参考。方法:60只昆明小鼠随机分为3组:对照组、低剂量模型组和高剂量模型组(n=20)。采用两个剂量NMDA受体拮抗剂MK-801建立谷氨酸低下精神分裂症小鼠模型,Western Blot分析小鼠海马组织中相关蛋白c-Fos及NADPH氧化酶亚基(p22、p47、p67)的表达变化。结果:低剂量MK-801能够显著增加模型组小鼠的自发活动及刻板行为,且与对照组相比有显著的统计学差异性(P<0.01),c-Fos蛋白及NADPH氧化酶蛋白亚基p22和p47的表达均明显高于对照组(P<0.01)。而高剂量的MK-801对小鼠具有后肢肌力障碍方面的毒性作用。结论:低剂量的MIK-801能诱导小鼠精神分裂症模型,且氧化应激及c-Fos的过表达参与了MK-801诱导的小鼠精神分裂症的发病过程。 Objective: To explore the pathogenesis mechanism of schizophrenia induced by MK-801 in order to provide reference for clinical research and treatment. Methods: Mice were divided into 3 groups, control group, low dose group and high dose group (n-20). The schizophrenia mice model was established by injecting MK-801, and the expression of c-Fos and NADPH oxidase units was detected by Western blot. Results: The activity distance and stereotyped behavior were enhanced in the low dose and high dose of MK-801 group (P〈0.01), and the expression of c-los, and the NADPH oxidase units, p22 and p47 were upregulated greatly compared with control group (P〈0.01). But high dose of MK-801 indicated toxic role for myodynamia disorder of legs. Conclusion: c-Fos overexpression and oxidative stress participated in the pathogenesis of schizophrenia in mice induced by MK-801.
出处 《现代生物医学进展》 CAS 2015年第22期4252-4256,共5页 Progress in Modern Biomedicine
基金 国家自然科学基金青年项目(31200844)
关键词 精神分裂症 MK-801 C-FOS 氧化应激 Schizophrenia MK-801 c-Fos Oxidative stress
  • 相关文献

参考文献23

  • 1Brennand KJ, Landek-Salgado MA, Sawa A. Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells[J]. Bio psyc, 2014, 75(12): 936-944.
  • 2Gurovich IY, Schmukler AB, Storozhakova YA, et al. Depressive symptoms diagnosis and treatment of schizophrenia and schizophrenia spectrum disorders in Russian clinical practice [J]. Zhurnal nevrologii i psikhiatrii imcni S.S. Korsakova, 2013, 113 (11 Pt 2): 28-33.
  • 3Foussias G, Agid O, Fervaha G, et al. Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders [J]. Eur neuropsy, 2014, 24 (5): 693-709.
  • 4Volavka J, Czobor P, Citrome L, et al. Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study[J]. CNS spectrums, 2012, 10(7): 1-8.
  • 5Xiao Y, Lui S, Deng W, et al. Altered Cortical Thickness Related to Clinical Severity But Not the Untreated Disease Duration in Schizophrenia[J]. Schizophrenia bull, 2013, 11 (3): 34-39.
  • 6Tarbox SI, Addington J, Cadenhead KS, et al. Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders[J]. Psychiatry research, 2014, 215(1): 52-60.
  • 7Vaisanen J, Ihalainen J, Tanila H, et al. Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia[J]. Cellular mol neuro, 2004, 24(6): 769-780.
  • 8Zuo DY, Cao Y, Zhang L, et al. Effects of acute and chronic administration of MK-801 on c-Fos protein expression in mice brain regions implicated in schizophrenia with or without clozapine [J]. Prog Ncuro-psy, 2009, 33(2): 290-295.
  • 9Barak S, Weiner I. The M (1)/M (4) preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia [J]. Int J neuropsych, 2011, 14(9): 1233-1246.
  • 10Eyjolfsson EM, Brenner E, Kondziella D, et al. Repeated injection of MK801: an animal model of schizophrenia? [J]. Neurochem int, 2006, 48(6-7): 541-546.

二级参考文献34

  • 1杨闯,郭兰婷,郭田友.谷氨酸受体与精神分裂症[J].中国神经精神疾病杂志,2005,31(3). 被引量:3
  • 2赵建中,姚加平.婴幼儿感染者血清TNF、IL-6、IL-8联检的临床意义[J].放射免疫学杂志,2005,18(3):185-186. 被引量:35
  • 3凌四海,郭实士,杨铁生,王传跃,汤宜朗,蔡焯基,翁永振.精神分裂症患者血中S100b蛋白和抗脑抗体的研究[J].中国神经精神疾病杂志,2005,31(4):278-281. 被引量:17
  • 4安宝富,张明廉,袁国桢,姚建军.一氧化氮与精神分裂症[J].临床精神医学杂志,2005,15(5):309-310. 被引量:4
  • 5Boulanger CH,Luscher TF.Releases of endothelin from the porcine aorta inhibition by endothelin derived nitric oxide[J].J Clin Invest,1990,85:587-589.
  • 6Anggard E.Nitric oxide mediator muderar and medicine[J].Lancet,1994,343:11-12.
  • 7Vornov J J, Tasker R C, CoyleJ T, et al. Delayed protection by MK801 and tetrodotoxin iu rat organtypic hippocampal culture model of ischemia[J]. Stroke, 1994,25:457-461.
  • 8She W, Zhang G, Zhang G. Nuclear factor kappa B activation is mediated by NMDA and non-NMDA receptor and L-type vohagegated Ca2+ channel following severe global ischemia in rat hippocampus[J]. Brain Res. 2002.933(1):23-30.
  • 9Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: quarreland harmony among siblings [J].J Cell Sci, 2004,117:5965- 5973.
  • 10McBride K, Charron F, Lefebvre C, et a l. Interaction with GATA transcription factors provides a mechanism tbr cell-specific effects of c-fos[J]. Oncogene, 2003,22:8403-8412.

共引文献14

同被引文献36

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部